Cannabis and lung cancer

Reece, A. S.

Source: Eur Respir J 2008; 32: 238-239

Journal Issue: July

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Reece, A. S.. Cannabis and lung cancer. Eur Respir J 2008; 32: 238-239

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Opium and lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 702s Year: 2006
Smoking and lung cancer Source: International Congress 2018 – Effect of tobacco use on health Year: 2018
Cannabis use and risk of lung cancer: a case-control study Source: Eur Respir J 2008; 31: 280-286 Year: 2008
Aerosoltherapy in lung cancer Source: Annual Congress 2008 - Therapy in thoracic oncology Year: 2008
Venothromboembolism in lung cancer Source: Eur Respir J 2007; 30: Suppl. 51, 601s Year: 2007
Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006
Non-small cell lung cancer in never-smokers Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer Year: 2016
Screening for lung cancer Source: International Congress 2017 – Lung cancer for the pulmonologist Year: 2017
Metabolomics in lung cancer Source: Annual Congress 2010 - Biomarkers for lung cancer Year: 2010
Cannabis: the next villain on the lung cancer battlefield? Source: Eur Respir J 2008; 31: 227-228 Year: 2008
Small cell lung cancer in never-smokers Source: Eur Respir J 2016; 47: 947-953 Year: 2016
Smoking and lung cancer in Albania Source: International Congress 2018 – Respiratory epidemiology: from infectious diseases to lung cancer Year: 2018
Update on nonsmall cell lung cancer Source: Eur Respir Rev 2010 19: 173-185 Year: 2010
Biological therapies in nonsmall cell lung cancer Source: Eur Respir J , 49 (3) 1601520; DOI: 10.1183/13993003.01520-2016 Year: 2017
Immunotherapies for lung cancer Source: International Congress 2018 – ME12 Immunotherapies for lung cancer FULLY BOOKED Year: 2018
Nonsmall cell lung cancer Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I Year: 2012
Anemia during lung cancer Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement Year: 2018
Personalised medicine for nonsmall cell lung cancer Source: Eur Respir Rev, 26 (146) 170066; 10.1183/16000617.0066-2017 Year: 2017
New treatment options for nonsmall cell lung cancer and small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006